If we look at the numbers, the trajectory of GLP-1 (glucagon-like peptide-1) receptor agonists is not just a growth story
You are overweight or obese, especially if weight gain is worsening blood sugar, cholesterol, blood pressure, fatty liver risk, inflammation, or joint pain
Quick Answer: GLP-1 medications typically make you feel full earlier and reduce hunger by slowing stomach emptying and affecting brain appetite centers, though initial side effects like nausea and bloating are common
In just a few years, Novo Nordisk had come to define the entire market
It is worth noting, however, that the risk is lower after gastric banding than after procedures with a malabsorptive component, such as Roux-en-Y gastric bypass or sleeve gastrectomy, because LAGB does not bypass or remove any part of the digestive tract
It can be used as a means to celebrate, socialize, or simply just provide fuel for the body